Tinnitus Week takes place from 5-11 February 2018 and is an international awareness initiative led by a group of organisations, including the British Tinnitus Association, American Tinnitus Association, Tinnitus Hub and the Tinnitus Research Initiative.
The aim of the week is to raise awareness of the condition, which affects approximately 1 in 10 of the population. The British Tinnitus Association campaign for the week will focus on children and young people.
The ‘Kids Talk Tinnitus’ campaign will engage with children, parents and schools to raise awareness of tinnitus amongst young people and drive the use of relevant support and resources. These can be found at www.tinnitus.org.uk/Pages/Category/tinnitus-in-children.
A new website has been set up, as a central resource collecting all the initiatives which will be taking place in 2018. This website can be found at www.tinnitusweek.com.
Find out more about Tinnitus Week here.
Only two-fifths (41 per cent) of NHS audiology departments give tinnitus sufferers access to four key services needed to help manage their condition, according to a new report from charity Action on Hearing Loss launched to mark Tinnitus Awareness Week.
Freedom of Information requests, issued by the charity to every NHS adult audiology provider across the UK, reveals a postcode lottery of care for tinnitus patients with six audiology units not providing any tinnitus services at all and a further nine units having had to reduce services over the past two years.
View the research briefing here
To mark Tinnitus Awareness Week (2 – 8 February), UK charity Action on Hearing Loss
announced a major investment to fund a new study at Newcastle University, which aims to
accelerate the development of future tinnitus treatments.
Six million people in the UK are affected by tinnitus every day – ranging from a light buzzing to a
constant roar in the ears and head – with 600,000 seriously affected by the condition, which can
have a detrimental effect on quality of life including bouts of anxiety, difficulties socialising and
problems sleeping or being able to concentrate at work.
The three year, £300,000 project will be led by Dr Mark Cunningham at Newcastle University and
will involve researchers at Leicester University and the biotechnology company Autifony
Therapeutics Ltd, who are currently conducting a clinical trial of a drug for tinnitus.
The pioneering research aims to bridge the gap between promising laboratory research
discoveries and testing new medicines in tinnitus patients.
View the full press release here